SUMO-1 CRISPR Knockout and Activation Products (h)

SUMO-1 CRISPR Knockout and Activation Plasmids (h) designed to edit, knockdown or upregulate human SUMO-1 gene expression

CRISPR/Cas advancements for genome editing, diagnosis, therapeutics, and vaccine development for Plasmodium parasites, and genetic engineering of Anopheles mosquito vector - ScienceDirect

Genome-wide binding of the CRISPR endonuclease Cas9 in mammalian cells

Frontiers SUMO and SUMOylation Pathway at the Forefront of Host Immune Response

Signalling mechanisms and cellular functions of SUMO

Exo1-protected DNA nicks direct crossover formation in meiosis

FAT10 inhibits SUMO activation by AOS1/UBA2. a In vitro

SUMO Proteomics Analyses Identify Protein Inhibitor of Activated STAT-Mediated Regulatory Networks Involved in Cell Cycle and Cell Proliferation

CRISPR/Cas9-engineered mesenchymal stromal/stem cells and their extracellular vesicles: A new approach to overcoming cell therapy limitations - ScienceDirect

Biology, Free Full-Text

SUMO-1 CRISPR Knockout and Activation Products (h)

human USE1-specific CRISPR/Cas9 KO Plasmid, HDR Plasmid, Double Nickase Plasmids, CRISPR Activation Plasmids and Lentiviral Activation Particles

USE1 CRISPR Plasmids (h)

A Chemical Toolbox for Labeling and Degrading Engineered Cas Proteins

Sumoylation and Regulation of Cardiac Gene Expression

SUMO‐regulated mitochondrial function in Parkinson's disease - Guerra de Souza - 2016 - Journal of Neurochemistry - Wiley Online Library

IJMS, Free Full-Text